Welcome to LookChem.com Sign In|Join Free
  • or
(3S)-1-[(2S,3S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(6-methoxypyridin-3-yl)phenyl]-1-oxobutanyl]-3-fluoropyrrolidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

876625-74-0

Post Buying Request

876625-74-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

876625-74-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 876625-74-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,6,6,2 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 876625-74:
(8*8)+(7*7)+(6*6)+(5*6)+(4*2)+(3*5)+(2*7)+(1*4)=220
220 % 10 = 0
So 876625-74-0 is a valid CAS Registry Number.

876625-74-0Relevant academic research and scientific papers

Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitors

Xu, Jinyou,Wei, Lan,Mathvink, Robert,Edmondson, Scott D.,Mastracchio, Anthony,Eiermann, George J.,He, Huaibing,Leone, Joseph F.,Leiting, Barbara,Lyons, Kathryn A.,Marsilio, Frank,Patel, Reshma A.,Petrov, Aleksandr,Wu, Joseph K.,Thornberry, Nancy A.,Weber, Ann E.

, p. 1346 - 1349 (2007/10/03)

anti-Substituted β-methylphenylalanine derived amides have been shown to be potent DPP-IV inhibitors exhibiting excellent selectivity over both DPP8 and DPP9. The optimized compound exhibited good pharmacokinetic profiles in three preclinical species.

PHENYLALANINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

-

, (2010/02/07)

The present invention is directed to phenylalanine derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 876625-74-0